Correlation Between Agilent Technologies and Capricor Therapeutics

Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Agilent Technologies and Capricor Therapeutics, you can compare the effects of market volatilities on Agilent Technologies and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Capricor Therapeutics.

Diversification Opportunities for Agilent Technologies and Capricor Therapeutics

-0.34

Correlation Coefficient

Agilent Technologies  Capricor Therapeutics

Very good diversification

The 3 months correlation between Agilent and Capricor is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Capricor Therapeutics go up and down completely randomly.

Pair Corralation between Agilent Technologies and Capricor Therapeutics

Taking into account the 90-day investment horizon Agilent Technologies is expected to generate 17.95 times less return on investment than Capricor Therapeutics. But when comparing it to its historical volatility, Agilent Technologies is 5.89 times less risky than Capricor Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  484.00  in Capricor Therapeutics on September 27, 2024 and sell it today you would earn a total of  917.00  from holding Capricor Therapeutics or generate 189.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Agilent Technologies  vs.  Capricor Therapeutics

Agilent Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Agilent Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Capricor Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Agilent Technologies and Capricor Therapeutics

The main advantage of trading using opposite Agilent Technologies and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.

The idea behind Agilent Technologies and Capricor Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.